Halia Therapeutics Reveals Promising Preclinical Obesity Data: HT-6184 and Semaglutide Combination Enhances Weight Loss and Preserves Lean Muscle Mass

September 23, 2024 UCBN News, Syndication Comments Off on Halia Therapeutics Reveals Promising Preclinical Obesity Data: HT-6184 and Semaglutide Combination Enhances Weight Loss and Preserves Lean Muscle Mass

LEHI, Utah, Sept. 23, 2024 /PRNewswire/ — Halia Therapeutics, Inc. (Halia), a clinical-stage biopharmaceutical company advancing novel therapies for inflammation-related diseases, today announced promising preclinical results from their investigational compound HT-6184, combined with the…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks

Related Articles

No Picture
News

Comagine Health and the Utah Health Information Network (UHIN) Announce Affiliation

April 18, 2024 UCBN News, Syndication Comments Off on Comagine Health and the Utah Health Information Network (UHIN) Announce Affiliation

Comagine Health, a national nonprofit health care consulting firm, and the Utah Health Information Network (UHIN), a leading health care information technology organization, recently announced they are affiliating. SEATTLE, April 17, 2024 /PRNewswire-PRWeb/ — Comagine […]

No Picture
News

Capricor Therapeutics Presents New Data Demonstrating a Scalable Framework for Loading Therapeutic Oligonucleotides into Exosomes at AAEV 2025

November 24, 2025 UCBN News, Syndication Comments Off on Capricor Therapeutics Presents New Data Demonstrating a Scalable Framework for Loading Therapeutic Oligonucleotides into Exosomes at AAEV 2025

–Findings support the versatility of Capricor’s exosome technology, enabling efficient and scalable loading of siRNAs and PMOs to support future clinical development– SAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) — Capricor Therapeutics, Inc., (NASDAQ: CAPR), […]